Showing results (31-40 of 6,842) with videos related to
Sort By:
Pageof 685
Health Affairs (Project Hope)|September 10, 2009
Is the United States ready for QALYs?Peter J Neumann, Dan GreenbergClinicoeconomics and Outcomes Research : CEOR|October 3, 2024
Consideration for Health Disparities in Value Assessment FrameworksDominique Seo, Divya Patil, Joe Vandigo, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 31, 2002
FDA actions against misleading or unsubstantiated economic and quality-of-life promotional claims: an analysis of warning letters and notices of violationKate A Stewart, Peter J NeumannExpert Review of Pharmacoeconomics & Outcomes Research|October 22, 2013
A survey of individuals in US-based pharmaceutical industry HEOR departments: attitudes on policy topicsPeter J Neumann, Cayla J SaretAlzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 18, 2008
Decision analytic models for Alzheimer's disease: state of the art and future directionsJoshua T Cohen, Peter J NeumannValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 23, 2015
When Does FDAMA Section 114 Apply? Ten Case StudiesPeter J Neumann, Cayla J SaretPharmacoeconomics|October 28, 2006
Economic evaluation in the US: what is the missing link?Peter J Neumann, Sean D SullivanThe Synthesis Project. Research Synthesis Report|November 5, 2011
Cost savings and cost-effectiveness of clinical preventive carePeter J Neumann, Joshua T CohenHealth Policy (Amsterdam, Netherlands)|October 10, 2009
Personalized medicine: factors influencing reimbursementLisa M Meckley, Peter J NeumannAlzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2012
The economics of mild cognitive impairmentPei-Jung Lin, Peter J NeumannPageof 685